Skip to content
Medical Health Aged Care

Estia Health to acquire seven residential aged care homes from Aurrum Aged Care

Estia Health 2 mins read

MEDIA RELEASE

 

Aurrum Aged Care (‘Aurrum’) has accepted an approach from Estia Health to acquire their seven residential aged care homes:

 

  • Estia Health increases investment and presence in NSW and Victoria
  • No change in the arrangements for Aurrum residents
  • Continuity of employment for home-based Aurrum employees

 

Estia Health and Aurrum Aged Care have announced that Estia Health will acquire the three homes on the Central Coast of New South Wales (Erina/Terrigal Drive, Norah Head, Wyoming) and the four homes in Melbourne (Brunswick, Healesville, Plenty, Reservoir) currently operated by Aurrum. It is expected that Estia Health will operate the homes from 1 April 2025.

 

Sean Bilton, CEO Estia Health said: “We are delighted that we are able to increase our commitment of care and services for older people through the management of approximately 800 additional residential aged care places across these seven homes, including entry into the Central Coast of NSW to complement existing homes in the Hunter and Mid North Coast regions.”

 

Estia Health and Aurrum’s management teams met with Aurrum’s residents, their families, and employees this week to outline the transition process and respond to questions.

Aurrum and Estia Health are committed to working closely together to support residents, their families, and employees through a smooth and successful transfer of ownership and management.

 

“We want to assure all residents and their families that they will continue to receive the same dedicated care and services from the same people that they always have,” Mr Bilton said. “As a provider of 78 residential aged care homes across Australia, we are proud to offer individualised care and support to our residents and their families at an incredibly important time in their lives.”

 

Adam Wilson, Aurrum representative, said: “After building Aurrum aged care over the last decade into a leading aged care provider, we have made the considered decision to sell to Estia Health. Following a comprehensive due diligence process, we are pleased that Estia Health is both well placed to acquire the homes and will ensure continuity of quality care for our residents. We believe our staff will also enjoy additional career opportunities and benefits. We believe that being part of a larger scale organisation will increasingly be a key advantage to the long-term success of aged care providers.”

 

Ends


About us:

About Estia Health

Estia Health is one of Australia’s leading aged care providers, operating 78 homes across Queensland, Victoria, South Australia, and New South Wales. Estia Health cares for over 8,000 residents annually and supports them and their families at an important time in their lives.

Our 11,000 employees are proud of the contribution they make to enrich and celebrate the lives of our residents and their families through exceptional care and services.

For more information, visit www.estiahealth.com.au

 About Aurrum Aged Care

Aurrum Aged Care, established in 2013, has a portfolio of approximately 800 places in Victoria and New South Wales. The Aurrum Living Life person centred care model is built on a philosophy of providing person centred care excellence to residents whilst offering premium quality accommodation, lifestyle and dining experiences.

For more information, visit https://aurrum.com.au


Contact details:

For Estia media enquiries: 
Julie Connolly
John Connolly & Partners
[email protected]

For Aurrum media enquiries:
John Frey
Brighton Corporate Communications Counsel 
[email protected]

 

 

Media

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.